Quinn Opportunity Partners’s Astria Therapeutics ATXS Stock Holding History

Quinn Opportunity Partners’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-120,000	Closed	-$1.57M	–	364
2025 Q4	$1.57M	Buy	+120,000	New	+$1.43M	0.07%	188

Quinn Opportunity Partners's ATXS Position: Q1 2026 in Review

Quinn Opportunity Partners sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 120,000 shares — an estimated $1.57M sold.

Quinn Opportunity Partners first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $1.57M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Quinn Opportunity Partners reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Quinn Opportunity Partners sold 120,000 Astria Therapeutics shares in Q1 2026, an estimated $1.57M.
Quinn Opportunity Partners first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
Quinn Opportunity Partners's Astria Therapeutics position peaked at $1.57M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Quinn Opportunity Partners's 13F filing for Q1 2026, filed 15 May 2026.